(Total Views: 442)
Posted On: 09/16/2020 7:56:19 PM
Post# of 148936
Little gem of management thinking with regards to dealing with BP on the last question in the Q&A:
Either they pay a shit ton of money to buy leronlimab/Cytodyn outright or Cytodyn moves forward on their own. No separate licenses based on use. Impossible to price by indication since its already been priced for HIV.
Either they pay a shit ton of money to buy leronlimab/Cytodyn outright or Cytodyn moves forward on their own. No separate licenses based on use. Impossible to price by indication since its already been priced for HIV.
(0)
(0)Scroll down for more posts ▼
